National Association of Testing Authorities, Australia
Scope of Accreditation
Queensland Health - Forensic and Scientific Services
Site
Forensic and Scientific Services
Accreditation No.
41
Site No.
13096
Date of Accreditation
26 Feb 1998
Contact
Assoc Prof Amy Jennison
P: +61 0422408784
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Leptospirosis Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
27 Feb 2025
Last Activity Date
28 Jul 2022
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Blood | Leptospira spp. |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Serum | Leptospira spp. |
| Microbiology - Serology of infection - Microbial typing | Serum | Leptospiral agglutination test |
Microbiology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
27 Feb 2025
Last Activity Date
28 Jul 2022
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; Sputum; Synovial fluid; Tissues | Pathogenic identification and antibiotic susceptibility |
| Aspirates; Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; Sputum; Synovial fluid; Tissues; Vomitus | Pathogenic identification | |
| Microbiology - Bacteriology - Public health investigation and/or monitoring of outbreaks of infection | Blood; Body fluids; Cerebrospinal fluid (CSF); Faeces; Isolates; Sputum; Tissues; Vomitus | Detection and characterisation of bacteria (including identification and typing) |
| Detection and characterisation of bacteria (including identification and typing) |
Molecular Microbiology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
27 Feb 2025
Last Activity Date
28 Jul 2022
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Bioinformatic analysis | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; Sputum; Tissues; Vomitus | Pathogenic identification and typing |
| Faeces | Pathogenic identification and typing | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids by whole genome sequencing | Bacterial isolates; Microbial nucleic acids | Resistance |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Isolates | Viable DNA for sequencing |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Extracted DNA | DNA sequence analysis |
| Microbiology - Molecular biology - Microbial genotyping | Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; Isolates; Tissues; Vomitus | Other microbes |
| Microbiology - Molecular biology - Microbial genotyping by whole genome sequencing studies | Isolates | Other microbes |
| Nasopharyngeal swabs; Oropharyngeal swabs; Swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Molecular biology - Public health investigation and/or monitoring | Bacterial isolates; Microbial nucleic acids | Organism characterisation for patient management; Phylogenetic analysis |
| Faeces | Detection and characterisation of organisms (including identification and typing) |
Virology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
27 Feb 2025
Last Activity Date
28 Jul 2022
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Dry swabs; General swabs; Tissues | Orientia tsutsugamushi (scrub typhus) |
| Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Dry swabs; Tissues | Rickettsia genus-specific | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Aspirates; Bronchial washings; Cell culture; Faeces; Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabsbronchial | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Blood; Cerebrospinal fluid (CSF); Dry swabs; Isolates; Serum; Tissues; Urine | Hendra virus | |
| Henipah group | ||
| Hendra virus | ||
| Nipah virus | ||
| Blood; Serum | Arenavirus group | |
| Bronchoalveolar lavage; Faeces; Respiratory specimens; Sputum | Human coronavirus MERS ORF1a gene; Human coronavirus MERS UpE gene | |
| Bronchoalveolar lavage; Faeces; Respiratory specimens; Sputum; Tissues | Coronavirus Pan | |
| Cell culture; Faeces; Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Cerebrospinal fluid (CSF); Dry swabs | Enterovirus group | |
| Enterovirus 71 | ||
| Cerebrospinal fluid (CSF); Dry swabs; Faeces; Isolates | Enterovirus D68 | |
| Enterovirus; Enterovirus 71 | ||
| Cerebrospinal fluid (CSF); Dry swabs; Isolates; Serum; Tissues; Urine | Measles virus | |
| Mumps virus | ||
| Rubella virus | ||
| Measles virus; Measles virus - Vaccine strain | ||
| Mumps virus | ||
| Rubella virus | ||
| Cerebrospinal fluid (CSF); Faeces; Isolates; Serum; Tissues; Vomitus | Mamastrovirus type 1; Mamastrovirus type 6 | |
| Cerebrospinal fluid (CSF); Isolates; Saliva; Serum; Tissues | Rabies virus | |
| Lyssavirus group | ||
| Australian bat lyssavirus (ABLV); Australian bat lyssavirus (ABLV) - Yellow belly strain | ||
| Cerebrospinal fluid (CSF); Isolates; Serum | Lymphocytic choriomeningitis virus | |
| Cerebrospinal fluid (CSF); Isolates; Serum; Tissues | Dengue virus 1 | |
| Mayaro virus | ||
| Zika virus - African strain; Zika virus - Pacific strain E gene | ||
| Yellow fever virus | ||
| Dengue virus 2 | ||
| Dengue virus | ||
| Filovirus group | ||
| Rift Valley fever virus | ||
| Murray Valley encephalitis virus | ||
| Zika virus - Pacific strain NS1 gene | ||
| Chikungunya virus - Mauritius strain | ||
| Alphavirus | ||
| West Nile virus | ||
| Dengue virus 4 | ||
| Dengue virus - Universal | ||
| Kunjin virus | ||
| Flavivirus group | ||
| Kokobera virus | ||
| Rotavirus | ||
| Dengue virus 3 | ||
| Japanese encephalitis virus (JEV) | ||
| Dry swabs; Faeces | Adenovirus | |
| Dry swabs; Isolates; Tissues | Parapox virus | |
| Parapox virus | ||
| Orthopox virus group | ||
| Molluscum contagiosum virus | ||
| Orthopox virus group | ||
| Dry swabs; Tissues | Varicella zoster virus (VZV) | |
| Varicella zoster virus (VZV) | ||
| Faeces | Astrovirus; Rotavirus | |
| Reovirus | ||
| Aichivirus | ||
| Sapovirus | ||
| Faeces; Serum | Puumula virus (PUUV) | |
| Hepatitis A virus (HAV) | ||
| Hepatitis A virus (HAV) | ||
| Hepatitis E virus (HEV) | ||
| Hepatitis E virus (HEV) | ||
| Hantavirus | ||
| Hantaan/Seoul virus | ||
| Faeces; Vomitus | Norovirus G1; Norovirus G2 | |
| Isolates; Serum | Alfuy virus (ALFV) | |
| Isolates; Serum; Tissues | Crimean-Congo hemorrhagic fever virus (CCHF) | |
| Ross River virus E gene | ||
| Barmah forest virus | ||
| Rift Valley fever virus | ||
| Nasopharyngeal aspirate; Respiratory specimens | Influenza A virus H1; Influenza A virus H5 | |
| Nasopharyngeal aspirate; Respiratory specimens; Sputum | Influenza A virus H5; Influenza B virus | |
| Influenza A virus H3 | ||
| Nasopharyngeal swabs; Respiratory specimens; Sputum | Influenza A virus H7 - 2013 China strain; Influenza A virus H7N9 - 2013 China strain; Influenza A virus N9 - 2013 China strain; Influenza B virus - Victoria lineage; Influenza B virus - Yamagata lineage | |
| Influenza A virus H1 - 2009 pandemic strain | ||
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Brain; Tissues; Viral culture cells | Australian bat lyssavirus (ABLV) |
| Cerebrospinal fluid (CSF) | Flavivirus IgM | |
| Serum | Flavivirus IgG; Flavivirus IgM | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgM antibodySARS-CoV-2 Spike 1; SARS-CoV-2 Spike 2; SARS-CoV-2 Nucleoprotein added as NSV 02/04/2024 | ||
| Alphavirus IgG antibody; Alphavirus IgM antibody; Australian bat lyssavirus (ABLV); Flavivirus; Hendra virus; Zika virus IgM antibody | ||
| Australian bat lyssavirus (ABLV); Hantavirus; Hendra virus; Lymphocytic choriomeningitis virus; Orientia tsutsugamushi (scrub typhus); Rickettsia australis; Rickettsia typhi | ||
| Hepatitis E virus (HEV); Rabies virus | ||
| Microbiology - Serology of infection - Microbial typing | Aspirates; Swabs; Washings | Influenza virus typing |
| Microbiology - Virology - Detection of pathogenic viruses | Aspirates; General swabs; Respiratory swabs and/or washings; Serum; Tissues | Pathogenic identification of unknown viruses |
| Blood; Cerebrospinal fluid (CSF); General swabs; Serum; Synovial fluid; Tissues; Urine | Alphavirus | |
| Flavivirus |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
41
Site No.
13096
Print date
25 Apr 2024
END OF SCOPE
